Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_assertion type Assertion NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_head.
- NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_assertion description "[The frequency of patients homozygous for the HTR2C haplotype A (-759C, -697G, and 23Cys) was significantly higher among clozapine-treated patients with obesity (BMI >/= 30 kg/m) compared with nonobese patients (P = 0.015; odds ratio, 28; 95% confidence interval, 2-380).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_provenance.
- NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_assertion evidence source_evidence_literature NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_provenance.
- NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_assertion SIO_000772 19142110 NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_provenance.
- NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_assertion wasDerivedFrom befree-20150227 NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_provenance.
- NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_assertion wasGeneratedBy ECO_0000203 NP471817.RAl6HGn4beIDO4zi-8DnaXx_ES-8XP_sDgdzLr8bL7Hes130_provenance.